Sign In
Last checked at 
24 Sep 2014 12:12
ο»Ώ
24 September 2014
Β
Allergy Therapeutics plc
("Allergy Therapeutics" or the "Company")
Β
Annual Report and Accounts
Β
Β
The Annual Report and Accounts for the year ended 30 June 2014 are available on the Company's website in the InvestorΒ RelationsΒ section.Β TheyΒ canΒ beΒ locatedΒ at http://www.allergytherapeutics.com/uploads/consolidatedyearend2014.pdf.
The shareholders copy of the Annual Report and Accounts for the year end 30 June 2014 will be posted to shareholders in mid-October together with the Notice of the Annual General Meeting.
Β
For further information
Allergy Therapeutics | +44 (0) 1903 845 820 |
Manuel Llobet, Chief Executive Officer Ian Postlethwaite, Finance Director | |
Peel Hunt LLP | +44 (0) 20 7418 8900 |
James Steel Clare Terlouw | |
FTI Consulting | +44 (0) 20 3727 1000 |
Simon Conway Victoria Foster Mitchell |
Β
Β
Notes to editors
Β
About Allergy Therapeutics
Allergy Therapeutics is a specialty pharmaceutical company focused on allergy vaccination. It has a growing business achieving revenue in the current financial year of Β£42 million mainly in Europe through its own sales and marketing infrastructure and further afield through distributors. The Company is expanding its infrastructure into the Emerging Markets.
Β
Β
Β
Follow the stocks
